Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0044
+0.0004 (10.00%)
Apr 10, 2026, 5:35 PM CET
Market Cap390.24K -32.6%
Revenue (ttm)2.00K -97.6%
Net Income1.96M
EPS0.40
Shares Out88.69M
PE Ratio0.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume428,754
Average Volume533,654
Open0.0040
Previous Close0.0040
Day's Range0.0040 - 0.0044
52-Week Range0.0040 - 0.1095
Beta-0.04
RSI39.51
Earnings DateApr 3, 2026

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements